JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Abstract Details

Activity Number: 298
Type: Contributed
Date/Time: Tuesday, July 31, 2012 : 8:30 AM to 10:30 AM
Sponsor: Biopharmaceutical Section
Abstract - #305227
Title: A Hybrid Bayesian/Frequentist Two-Stage Randomized Phase II Design
Author(s): Dawn Peters*+
Companies: Oregon Health and Science University
Address: 3181 SW Sam Jackson Park Road, Portland, OR, 97239-3098, United States
Keywords: Phase II ; Two-stage ; Bayesian ; Randomized

There has been considerable discussion in the statistical community regarding the use of single-arm versus randomized two-arm designs for phase II studies assessing the promise of a new therapy. Points of contention include the extra resources needed for a two-arm study and the lack of a concurrent control in a one-arm study. In this paper we propose a hybrid Bayesian/frequentist two-stage partially randomized phase II design for assessing the efficacy of a new therapy. In the first (single-arm) stage, only the new therapy is provided to subjects and the decision to proceed to the second stage is based on Bayesian posterior probabilities that incorporate prior information on the new and standard therapies. At the second stage, subjects are randomized between the new and standard therapies and final inference in based on frequentist considerations only. Designs are constructed to satisfy Type I and Type II error constraints and optimality criteria are considered for design selection.

The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.

Back to the full JSM 2012 program

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.